Munafa Stock Market Course + Intraday & FNO calls 
RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
Dr Reddy's launches immuno-oncology drug Toripalimab in India for treating nasopharyngeal carcinoma
Dr. Reddy's Laboratories launched Zytorvi (Toripalimab), a novel immunotherapy drug for recurrent or metastatic nasopharyngeal carcinoma (NPC), a rare head and neck cancer. This marks India as the third country globally with access to this next-gen PD-1 in
Announcement as on 28 November 2024
Dr Reddy's launches drug for neck, head cancer
Dr Reddy's Laboratories launched toripalimab, an immune oncology drug for adults with a rare form of head and neck cancer, in India. This drug is for treating recurrent or metastatic nasopharyngeal carcinoma. It will be marketed under the name Zytorvi. Bef
Announcement as on 28 November 2024
Dr Reddy's Labs, Mankind Pharma riding on strong growth drivers
Indian pharmaceutical giants, Dr. Reddy's Labs and Mankind Pharma, reported impressive double-digit revenue growth in the September quarter. Dr. Reddy's achieved this milestone despite challenges in Europe and increased expenses, while Mankind Pharma thriv
Announcement as on 06 November 2024
Dr Reddy's Labs Q2 Results: Profit falls 15% YoY to Rs 1,255 crore, revenue up 17%
Dr Reddy's Labs Q2 Results: Healthcare major Dr Reddy's on Tuesday reported 15% drop in its consolidated net profit at Rs 1255 crore in the second quarter. It was Rs 1480 crore in the year-ago quarter.
Announcement as on 05 November 2024
Dr Reddy's Labs Q2 Preview: Healthy double-digit revenue growth seen, but PAT may fall
For the July-September 2024 period, net profit is expected to decline by 3% year-on-year, based on the average estimate from four brokerages. Sales, however, are projected to increase by 13% year-on-year, according to the estimates.
Announcement as on 04 November 2024
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 23 Thu Apr 2026 | 13.58 | 13.33 to 13.83 | 5.76% | 3.67 times |
| 22 Wed Apr 2026 | 12.84 | 12.81 to 13.04 | 0.55% | 1.38 times |
| 21 Tue Apr 2026 | 12.77 | 12.77 to 13.03 | -2.44% | 1.26 times |
| 20 Mon Apr 2026 | 13.09 | 13.05 to 13.17 | -1.58% | 0.84 times |
| 17 Fri Apr 2026 | 13.30 | 13.29 to 13.59 | 1.84% | 0.9 times |
| 16 Thu Apr 2026 | 13.06 | 12.97 to 13.13 | 0.93% | 0.81 times |
| 15 Wed Apr 2026 | 12.94 | 12.86 to 13.36 | -1.45% | 1.09 times |
| 14 Tue Apr 2026 | 13.13 | 13.12 to 13.37 | -1.06% | 1.06 times |
| 13 Mon Apr 2026 | 13.27 | 13.10 to 13.29 | -0.3% | 0.8 times |
| 10 Fri Apr 2026 | 13.31 | 13.31 to 13.60 | 0.38% | 0.77 times |
| 09 Thu Apr 2026 | 13.26 | 13.19 to 13.32 | 0.15% | 1.1 times |
| 08 Wed Apr 2026 | 13.24 | 12.96 to 13.28 | 2.24% | 1.58 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Hindi Video Most Important Stock Market Video. No Success Without This Formula
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
